Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat?
Ancylostoma caninum
Anthelmintics
Canine health
Hookworms
Resistance
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
09 Dec 2019
09 Dec 2019
Historique:
received:
23
08
2019
accepted:
30
11
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
29
4
2020
Statut:
epublish
Résumé
The canine hookworm, Ancylostoma caninum is the most prevalent and important intestinal nematode parasite of dogs in the USA. Hookworms are typically well controlled by treatment with all commonly used anthelmintics that are approved for this use in dogs. However, in the past few years, cases of recurrent/persistent canine hookworm infections appear to have dramatically increased, suggesting that anthelmintic resistance (AR) may have evolved in this parasite. These cases are highly overrepresented by greyhounds, but multiple other breeds are also represented. The aim of this study was to characterize several of these suspected resistant isolates using in vitro, genetic and clinical testing to determine if these cases represent true anthelmintic resistance in A. caninum. Fecal samples containing hookworm eggs from three cases of persistent hookworm infections; one from a greyhound, one from a miniature schnauzer and one from a hound-mix, were received by our laboratory. These were then used to establish infections in laboratory dogs and to perform egg hatch assays (EHA) and larval development assays (LDA) for detecting resistance to benzimidazoles and macrocyclic lactones, respectively. Additional EHA and LDA were performed on eggs recovered from the laboratory-induced infections. Fecal egg count reduction tests were performed to detect resistance to pyrantel. Deep amplicon sequencing assays were developed to measure the frequency of non-synonymous single nucleotide polymorphisms (SNP) at codons 167, 198 and 200 of the A. caninum isotype-1 β-tubulin gene. Resistance ratios for the three A. caninum isolates tested ranged from 6.0 to > 100 and 5.5 to 69.8 for the EHA and LDA, respectively. Following treatment with pyrantel, reduction in faecal egg counts was negative or 0%. Deep amplicon sequencing of the isotype-1 β-tubulin gene identified a high frequency of resistance-associated SNPs at codon 167 in all three resistant isolates and in two additional clinical cases. These data conclusively demonstrate multiple anthelmintic resistance in multiple independent isolates of A. caninum, strongly suggesting that this is an emerging problem in the USA. Furthermore, evidence suggest that these resistant hookworms originate from racing greyhound farms and kennels, though additional research is needed to confirm this.
Sections du résumé
BACKGROUND
BACKGROUND
The canine hookworm, Ancylostoma caninum is the most prevalent and important intestinal nematode parasite of dogs in the USA. Hookworms are typically well controlled by treatment with all commonly used anthelmintics that are approved for this use in dogs. However, in the past few years, cases of recurrent/persistent canine hookworm infections appear to have dramatically increased, suggesting that anthelmintic resistance (AR) may have evolved in this parasite. These cases are highly overrepresented by greyhounds, but multiple other breeds are also represented. The aim of this study was to characterize several of these suspected resistant isolates using in vitro, genetic and clinical testing to determine if these cases represent true anthelmintic resistance in A. caninum.
METHODS
METHODS
Fecal samples containing hookworm eggs from three cases of persistent hookworm infections; one from a greyhound, one from a miniature schnauzer and one from a hound-mix, were received by our laboratory. These were then used to establish infections in laboratory dogs and to perform egg hatch assays (EHA) and larval development assays (LDA) for detecting resistance to benzimidazoles and macrocyclic lactones, respectively. Additional EHA and LDA were performed on eggs recovered from the laboratory-induced infections. Fecal egg count reduction tests were performed to detect resistance to pyrantel. Deep amplicon sequencing assays were developed to measure the frequency of non-synonymous single nucleotide polymorphisms (SNP) at codons 167, 198 and 200 of the A. caninum isotype-1 β-tubulin gene.
RESULTS
RESULTS
Resistance ratios for the three A. caninum isolates tested ranged from 6.0 to > 100 and 5.5 to 69.8 for the EHA and LDA, respectively. Following treatment with pyrantel, reduction in faecal egg counts was negative or 0%. Deep amplicon sequencing of the isotype-1 β-tubulin gene identified a high frequency of resistance-associated SNPs at codon 167 in all three resistant isolates and in two additional clinical cases.
CONCLUSIONS
CONCLUSIONS
These data conclusively demonstrate multiple anthelmintic resistance in multiple independent isolates of A. caninum, strongly suggesting that this is an emerging problem in the USA. Furthermore, evidence suggest that these resistant hookworms originate from racing greyhound farms and kennels, though additional research is needed to confirm this.
Identifiants
pubmed: 31818311
doi: 10.1186/s13071-019-3828-6
pii: 10.1186/s13071-019-3828-6
pmc: PMC6902405
doi:
Substances chimiques
Anthelmintics
0
Pyrantel
4QIH0N49E7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
576Références
Antimicrob Agents Chemother. 2008 Nov;52(11):3980-6
pubmed: 18710918
Am J Trop Med Hyg. 2007 Apr;76(4):732-6
pubmed: 17426180
Mol Biochem Parasitol. 2002 Apr 9;120(2):297-300
pubmed: 11897135
Int J Parasitol. 2007 Jun;37(7):795-804
pubmed: 17307184
PLoS Negl Trop Dis. 2015 Feb 06;9(2):e0003494
pubmed: 25658086
Vet Parasitol. 2015 Apr 15;209(1-2):84-92
pubmed: 25725546
PLoS One. 2013 Aug 12;8(8):e70212
pubmed: 23950913
Mol Biochem Parasitol. 1994 Feb;63(2):299-303
pubmed: 7911975
Vet Parasitol. 2013 Dec 6;198(3-4):312-8
pubmed: 24126090
Vet Clin North Am Small Anim Pract. 1987 Nov;17(6):1341-54
pubmed: 3328392
Vet Parasitol. 1999 Aug 16;85(1):49-59
pubmed: 10447192
Vet Parasitol. 2015 May 30;210(1-2):114-7
pubmed: 25865406
Vet Parasitol. 2004 May 7;121(1-2):125-42
pubmed: 15110410
Parasit Vectors. 2019 Sep 5;12(1):430
pubmed: 31488192
Parasitol Res. 2001 Feb;87(2):122-5
pubmed: 11206108
Am J Trop Med Hyg. 1997 Jul;57(1):25-30
pubmed: 9242313
Int J Parasitol. 2012 May 1;42(5):469-79
pubmed: 22787588
Vet J. 1997 Jul;154(1):11-34
pubmed: 9265850
J Am Vet Med Assoc. 2008 Dec 15;233(12):1913-9
pubmed: 19072608
Genetics. 1995 Nov;141(3):1007-14
pubmed: 8582607
Parasitol Res. 2009 Sep;105(3):825-34
pubmed: 19452165
Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):230-240
pubmed: 27821282
Parasit Vectors. 2014 Aug 06;7:356
pubmed: 25095701
Vet Parasitol. 2014 Dec 15;206(3-4):313-6
pubmed: 25468029
Parasitol Res. 2015 Sep;114(9):3529-33
pubmed: 26122998
Int J Parasitol. 2017 Nov;47(13):893-902
pubmed: 28797791
Vet Parasitol. 2008 Apr 15;152(3-4):284-93
pubmed: 18242867
Int J Parasitol. 1981 Feb;11(1):35-41
pubmed: 7228476
Int J Parasitol. 1996 Jul;26(7):733-40
pubmed: 8894764
Parasit Vectors. 2018 Oct 9;11(1):540
pubmed: 30301454
Int J Parasitol. 2008 Aug;38(10):1149-60
pubmed: 18367189
Bull World Health Organ. 2003;81(5):343-52
pubmed: 12856052
Vet Parasitol. 2005 May 15;129(3-4):291-8
pubmed: 15845285
Int J Parasitol. 1988 Nov;18(7):885-936
pubmed: 3066771
Adv Parasitol. 2016;93:31-68
pubmed: 27238002
S Afr Med J. 1966 May 14;40(18):403-5
pubmed: 5949465
PLoS One. 2015 Dec 02;10(12):e0143559
pubmed: 26630572
Clin Microbiol Rev. 2001 Oct;14(4):689-703, table of contents
pubmed: 11585781
Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):585-9
pubmed: 7992348
Aust Vet J. 1980 May;56(5):239-51
pubmed: 7002142
Vet Rec. 1988 Apr 30;122(18):444
pubmed: 3394239
Am J Trop Med Hyg. 2013 Jun;88(6):1052-61
pubmed: 23458960
Vet Parasitol. 2009 May 12;161(3-4):213-7
pubmed: 19251366
J S Afr Vet Assoc. 1993 Mar;64(1):9-12
pubmed: 8496899
Int J Parasitol. 2000 Apr 10;30(4):347-55
pubmed: 10731559
Vet Parasitol. 2009 Dec 3;166(1-2):144-52
pubmed: 19716659
Vet Parasitol. 1992 Mar;41(3-4):329-33
pubmed: 1502793
Vet Parasitol. 2007 Feb 28;143(3-4):299-304
pubmed: 17011128
Mol Biochem Parasitol. 2004 Apr;134(2):281-4
pubmed: 15003848
Res Vet Sci. 1991 Mar;50(2):247-9
pubmed: 2034909
Int J Parasitol. 2005 Jun;35(7):803-11
pubmed: 15885696
Trends Parasitol. 2004 Oct;20(10):469-76
pubmed: 15363440
Exp Parasitol. 1979 Apr;47(2):246-53
pubmed: 437019
Vet Parasitol. 2019 Jan;265:7-14
pubmed: 30638523
J Vet Pharmacol Ther. 1999 Feb;22(1):2-5
pubmed: 10211710
N Z Vet J. 1987 Dec;35(12):215-6
pubmed: 16031355
Mol Biochem Parasitol. 1996 Aug;79(2):249-53
pubmed: 8855563
Parasit Vectors. 2016 Mar 02;9:123
pubmed: 26935065
J Am Anim Hosp Assoc. 2019 May/Jun;55(3):160-166
pubmed: 30870603
J Helminthol. 2019 Feb 21;94:e39
pubmed: 30789121
Int J Parasitol. 1995 Apr;25(4):463-70
pubmed: 7635622
Parasitology. 2009 Mar;136(3):349-58
pubmed: 19154653
Int J Parasitol. 2019 Jan;49(1):13-26
pubmed: 30471287
Int J Parasitol. 2001 Jul;31(9):949-59
pubmed: 11406143
Am J Trop Med Hyg. 2009 Jul;81(1):163-70
pubmed: 19556583
J Parasitol. 1968 Jun;54(3):426-9
pubmed: 5761146
Vet Parasitol. 2016 Apr 15;220:77-82
pubmed: 26995725
Vet Clin North Am Small Anim Pract. 2009 Nov;39(6):1091-107, vi-vii
pubmed: 19932365
Trends Parasitol. 2001 Sep;17(9):445-53
pubmed: 11530357
Vet Rec. 1989 Aug 12;125(7):153-4
pubmed: 2800272
Int J Parasitol Drugs Drug Resist. 2012 Apr 14;2:134-53
pubmed: 24533275
Acta Trop. 1996 Sep;62(1):23-44
pubmed: 8971276
Exp Parasitol. 1982 Dec;54(3):303-9
pubmed: 7151941
Int J Parasitol. 2019 Apr;49(5):397-406
pubmed: 30771359
Vet Parasitol. 2014 Aug 29;204(3-4):411-5
pubmed: 24916341
Res Vet Sci. 1977 May;22(3):386-7
pubmed: 560037
Int J Parasitol. 1991 Jul;21(4):429-40
pubmed: 1917283
Int J Parasitol. 2005 Apr 1;35(4):445-53
pubmed: 15777920
Trends Parasitol. 2004 Oct;20(10):477-81
pubmed: 15363441